MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with I

Imipramine

Imipramine 10mg tablets

Use with caution

Stability notes for Imipramine 10mg tablets

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 10mg tablets (Accord Healthcare Ltd).

Suppliers (8) of Imipramine 10mg tablets
Imipramine 10mg tablets (A A H Pharmaceuticals Ltd)
Imipramine 10mg tablets (Accord-UK Ltd)
Imipramine 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Imipramine 10mg tablets (Almus Pharmaceuticals Ltd)
Imipramine 10mg tablets (Crescent Pharma Ltd)
Imipramine 10mg tablets (Medihealth (Northern) Ltd)
Imipramine 10mg tablets (Phoenix Healthcare Distribution Ltd)
Imipramine 10mg tablets (Sigma Pharmaceuticals Plc)

Imipramine 25mg tablets

Use with caution

Stability notes for Imipramine 25mg tablets

Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.

Provenance

This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).

Suppliers (9) of Imipramine 25mg tablets
Imipramine 25mg tablets (A A H Pharmaceuticals Ltd)
Imipramine 25mg tablets (Accord-UK Ltd)
Imipramine 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Imipramine 25mg tablets (Almus Pharmaceuticals Ltd)
Imipramine 25mg tablets (Crescent Pharma Ltd)
Imipramine 25mg tablets (Medihealth (Northern) Ltd)
Imipramine 25mg tablets (Phoenix Healthcare Distribution Ltd)
Imipramine 25mg tablets (Relonchem Ltd)
Imipramine 25mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.